SUBSCRIBE
SUBSCRIBE

GSK Bio

NEWS
Deal-Starved Perrigo Company In Talks To Buy $5B Omega Pharma
Business
Novartis AG Quietly Leases Large Space In Philadelphia
October 31, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Five Prime Therapeutics, Inc. Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline
October 24, 2014
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
New Role Created At GlaxoSmithKline’s Vaccines Unit
October 23, 2014
 · 
1 min read
Business
Top 30 Life Science Startups To Watch In The U.S.
BioSpace is delighted to present its NextGen Bio “Class of 2015.” This list contains 30 life science companies that were launched no earlier than in 2011 and are headquartered in the United States.
October 23, 2014
 · 
15 min read
 · 
Mark Terry
Biotech Bay
GlaxoSmithKline’s Rising Star Under Pressure As Drugs Falter
October 22, 2014
 · 
1 min read
Deals
Job Cuts Loom Over GlaxoSmithKline As It Aims To Cut Costs; Eyes IPO Of HIV Unit
October 22, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
GlaxoSmithKline, Johnson & Johnson Join Forces To Make Millions Of Ebola Vaccine Doses
October 22, 2014
 · 
1 min read
Ebola Clinical Trials: Big Name Players In The Ebola Race
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
 · 
12 min read
Job Trends
GlaxoSmithKline Expands In North Carolina With Hiring Spree
October 14, 2014
 · 
2 min read
Load More
  • 2026 - Best Places to Work - Badge (1).png
JOBS
IN THE PRESS
Press Releases
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
May 28, 2025
 · 
9 min read
Press Releases
Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
November 12, 2024
 · 
4 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
 · 
7 min read
Press Releases
GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons
October 8, 2024
 · 
10 min read
Pharm Country
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
March 7, 2024
 · 
5 min read
Pharm Country
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
August 17, 2023
 · 
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
May 16, 2023
 · 
7 min read
Business
AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer
December 2, 2022
 · 
5 min read